Overview Vitamin D Pilot Study in Patients With Multiple Sclerosis Status: Completed Trial end date: 2000-06-01 Target enrollment: Participant gender: Summary Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI. Phase: Phase 1 Details Lead Sponsor: University of Wisconsin, MadisonTreatments: ErgocalciferolsVitamin DVitamins